Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scans.

Saved in:
Bibliographic Details
Title: Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scans.
Authors: Feizpour A; Florey Institute of Neuroscience and Mental Health, The University of Melbourne, 30 Royal Parade, Parkville, VIC, 3052, Australia; Department of Molecular Imaging & Therapy, Austin Health, 145 Studley Road, Heidelberg, VIC, 3084, Australia. Electronic address: azadeh.feizpour@florey.edu.au., Doré V; Department of Molecular Imaging & Therapy, Austin Health, 145 Studley Road, Heidelberg, VIC, 3084, Australia; The Australian e-Health Research Centre, CSIRO, 351 Royal Parade, Parkville, VIC, 3052, Australia., Bourgeat P; The Australian e-Health Research Centre, CSIRO, 296 Herston Rd, Herston, Qld, 4029, Australia., Doecke JD; The Australian e-Health Research Centre, CSIRO, 296 Herston Rd, Herston, Qld, 4029, Australia., Canovas R; The Australian e-Health Research Centre, CSIRO, 351 Royal Parade, Parkville, VIC, 3052, Australia., Laws SM; Centre for Precision Health, Edith Cowan University, 270 Joondalup Drive, Joondalup, WA, 6027, Australia; Collaborative Genomics and Translation Group, School of Medical and Health Sciences, Edith Cowan University, 270 Joondalup Drive, Joondalup, WA, 6027, Australia; Curtin Medical School, Curtin University, Kent Street, Bentley, WA, 6102, Australia., Porter T; Centre for Precision Health, Edith Cowan University, 270 Joondalup Drive, Joondalup, WA, 6027, Australia; Collaborative Genomics and Translation Group, School of Medical and Health Sciences, Edith Cowan University, 270 Joondalup Drive, Joondalup, WA, 6027, Australia; Curtin Medical School, Curtin University, Kent Street, Bentley, WA, 6102, Australia., Huang K; Department of Molecular Imaging & Therapy, Austin Health, 145 Studley Road, Heidelberg, VIC, 3084, Australia., Fowler C; Florey Institute of Neuroscience and Mental Health, The University of Melbourne, 30 Royal Parade, Parkville, VIC, 3052, Australia., Martins RN; Australian Alzheimer's Research Foundation, Nedlands, WA, 6009, Australia., Maruff P; Cogstate Ltd, 161 Collins St, Melbourne, VIC, 3000, Australia., Sohrabi HR; Centre for Healthy Ageing, Health Futures Institute, Murdoch University, WA, 6150, Australia; School of Psychology, Murdoch University, WA, 6150, Australia., Weiner MW; Department of Radiology, University of California at San Francisco, San Francisco, 505 Parnassus Avenue, San Francisco, CA, 94143, USA., Morris JC; Department of Neurology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, 63110, USA; Charles F. and Joanne Knight Alzheimer Disease Research Center (Knight ADRC), Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, 63110, USA., Benzinger TLS; Charles F. and Joanne Knight Alzheimer Disease Research Center (Knight ADRC), Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, 63110, USA; Department of Radiology, Washington University in St. Louis, 510 South Kingshighway Boulevard, St. Louis, MO, 63110, USA., Schindler SE; Department of Neurology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, 63110, USA; Charles F. and Joanne Knight Alzheimer Disease Research Center (Knight ADRC), Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, 63110, USA., Bateman RJ; Department of Neurology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, 63110, USA; Charles F. and Joanne Knight Alzheimer Disease Research Center (Knight ADRC), Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, 63110, USA; Tracy Family SILQ Center, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, 63110, USA., Li Y; Department of Neurology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, 63110, USA., Vitaliy O; Department of Neurology, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, 63110, USA; Tracy Family SILQ Center, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO, 63110, USA., Ward L; Florey Institute of Neuroscience and Mental Health, The University of Melbourne, 30 Royal Parade, Parkville, VIC, 3052, Australia., Mejan-Fripp J; The Australian e-Health Research Centre, CSIRO, 296 Herston Rd, Herston, Qld, 4029, Australia., Masters CL; Florey Institute of Neuroscience and Mental Health, The University of Melbourne, 30 Royal Parade, Parkville, VIC, 3052, Australia., Villemagne VL; Department of Psychiatry, University of Pittsburgh, 3811 O'Hara Street, Pittsburgh, PA, 15213, USA., Rowe CC; Florey Institute of Neuroscience and Mental Health, The University of Melbourne, 30 Royal Parade, Parkville, VIC, 3052, Australia; Department of Molecular Imaging & Therapy, Austin Health, 145 Studley Road, Heidelberg, VIC, 3084, Australia. Electronic address: christopher.rowe@austin.org.au.
Corporate Authors: ADOPIC Consortium (AIBL, ADNI, OASIS)
Source: The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2026 Feb; Vol. 13 (2), pp. 100455. Date of Electronic Publication: 2026 Jan 01.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101638820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2426-0266
DOI:10.1016/j.tjpad.2025.100455